Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Seminars in Nuclear Medicine
|
January 1, 1974
Radiopharmaceuticals for renal studies
L R Chervu, L M Freeman, M D Blaufox
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 1984
Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication
L R Chervu, B M Sundoro, M D Blaufox
Seminars in Nuclear Medicine
|
January 1, 1982
Radiopharmaceuticals for hepatobiliary imaging
L R Chervu, A D Nunn, M D Loberg
International Journal of Nuclear Medicine and Biology
|
December 1, 1977
Quality control of technetium-labelled lung imaging agents
L R Chervu, S R Vallabhajosula, M D Blaufox
The British Journal of Radiology
|
April 1, 1976
The organ distribution of 131I-tyrosyl somatostatin
P A Bardfeld, L R Chervu, D R Murty
Clinical Nuclear Medicine
|
March 1, 1988
Red blood cell labeling with technetium-99m. Effect of radiopaque contrast agents
J Finkel, L R Chervu, R G Bernstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1977
Use of 99mTc-Cu-DTPA complex as a renal function agent
L R Chervu, H B Lee, Q Goyal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1982
Thyroid uptake measurements with I-123: problems and pitfalls: concise communication
S Chervu, L R Chervu, P N Goodwin, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 1, 1988
Protein-losing enteropathy detected by 99mTc-labeled human serum albumin abdominal scintigraphy
J A Lan, L R Chervu, Z Marans, et al.
The Journal of Nuclear Medicine and Allied Sciences
|
October 1, 1988
Stability studies of 99m technetium labeled radiopharmaceuticals
L R Chervu, B D Vallabhajosyula, S B Chun, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Seminars in Nuclear Medicine
|
January 1, 1974
Radiopharmaceuticals for renal studies
L R Chervu, L M Freeman, M D Blaufox
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 1, 1984
Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication
L R Chervu, B M Sundoro, M D Blaufox
Seminars in Nuclear Medicine
|
January 1, 1982
Radiopharmaceuticals for hepatobiliary imaging
L R Chervu, A D Nunn, M D Loberg
International Journal of Nuclear Medicine and Biology
|
December 1, 1977
Quality control of technetium-labelled lung imaging agents
L R Chervu, S R Vallabhajosula, M D Blaufox
The British Journal of Radiology
|
April 1, 1976
The organ distribution of 131I-tyrosyl somatostatin
P A Bardfeld, L R Chervu, D R Murty
Clinical Nuclear Medicine
|
March 1, 1988
Red blood cell labeling with technetium-99m. Effect of radiopaque contrast agents
J Finkel, L R Chervu, R G Bernstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1977
Use of 99mTc-Cu-DTPA complex as a renal function agent
L R Chervu, H B Lee, Q Goyal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1982
Thyroid uptake measurements with I-123: problems and pitfalls: concise communication
S Chervu, L R Chervu, P N Goodwin, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 1, 1988
Protein-losing enteropathy detected by 99mTc-labeled human serum albumin abdominal scintigraphy
J A Lan, L R Chervu, Z Marans, et al.
The Journal of Nuclear Medicine and Allied Sciences
|
October 1, 1988
Stability studies of 99m technetium labeled radiopharmaceuticals
L R Chervu, B D Vallabhajosyula, S B Chun, et al.
Page
of 4